Previous 10 | Next 10 |
Image source: The Motley Fool. Guardant Health Inc (NASDAQ: GH) Q4 2020 Earnings Call Feb 24, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Guardant Health Inc (GH) Q4 2020 Earnings Call Transcript
Guardant Health (GH): Q4 GAAP EPS of -$0.94 misses by $0.35.Revenue of $78.32M (+24.5% Y/Y) beats by $1.59M.Adj. EBITDA loss was $29.8M, as compared to a $17.1M loss Y/Y.2021 Guidance: Revenue of $360-$370M, representing 26% to 29% growth Y/Y; Clinical volumes for 2021 are expected to be...
2020 Revenue Increased 34% Over Prior Year Period Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial r...
[[ACA]], [[ACAD]], [[ADPT]], [[AGI]], [[AMED]], [[ANSS]], [[APA]], [[AWK]], [[BILI]], [[BKNG]], [[CCRN]], [[CDNA]], [[CHDN]], [[CNXN]], [[CW]], [[DDD]], [[DOOR]], [[DRH]], [[ECPG]], [[EPR]], [[ESI]], [[ESTC]], [[FATE]], [[FNF]], [[FTI]], [[GBT]], [[GEF]], [[GH]], [[HCC]], [[ICLR]], [[INGN]], ...
Guardant Health (NASDAQ:GH) is scheduled to announce Q4 earnings results on Wednesday, February 24th, after market close.The consensus EPS Estimate is -$0.47 (-74.1% Y/Y) and the consensus Revenue Estimate is $76.73M (+22.0% Y/Y).Over the last 1 year, GH has beaten EPS estimates 100% of the t...
According to the U.S. Centers for Disease Control and Prevention (CDC), cancer is the second-leading cause of death in the U.S. (behind heart disease), claiming 599,601 lives in 2019. On the bright side, there has been notable progress in the multi-pronged approach to fight this disease. On...
Insider buying increased significantly last week. Notable Insider Buys: The Greenbrier Companies, Inc., Dun & Bradstreet Holdings, Inc., CuriosityStream Inc., Affiliated Managers Group, Inc., Calix, Inc. Notable Insider Sells: Penn National Gaming, Inc., Guardant Health, Inc.,...
Insider buying decreased last week. Notable Insider Buys: MSC Industrial Direct Co., Inc., Harley-Davidson, Inc., Brown & Brown, Inc., Alliance Data Systems Corporation, Crown Castle International Corp. (REIT). Notable Insider Sells: DocuSign, Inc., Guardant Health, Inc., Face...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the fourth quarter and full year 2020 after market close on Wednesday, February 24, 2021. Company management will be webcasting a corresponding conference call ...
Insiders stepped up their buying last week. Notable Insider Buys: Teledyne Technologies Incorporated, B. Riley Financial, Inc., Intel Corporation, Guaranty Bancshares, Inc., and FuelCell Energy, Inc. Notable Insider Sells: Facebook, Inc., Guardant Health, Inc., Workhorse Group Inc...
News, Short Squeeze, Breakout and More Instantly...
Shield is first blood test approved by FDA as a primary screening option for colorectal cancer and that meets performance requirements for Medicare coverage Blood test offers easy, convenient and pleasant screening option with potential for improving colorectal cancer screening rates ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the second quarter 2024 after market close on Wednesday, August 7, 2024. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Ti...
Running on Guardant Infinity™ smart liquid biopsy platform, new Guardant360 test covers over 10 times more genes, including all guideline-recommended genomic biomarkers across advanced solid tumors, and quantifies tumor burden with 10 times higher sensitivity Upgraded test covered ...